Extensive small-cell lung cancer. A randomized comparison of two chemotheraphy programs with early crossover in instances of failure

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

WHO Handbook for Reporting Results of Cancer Treatment

1982 • 2,214 citations

Cancer: Principles and Practice of Oncology.

1988 • 1,907 citations

[Cancer of the lung].

1954 • 861 citations

Rationale for the use of alternating non-cross-resistant chemotherapy.

1982 • 545 citations

Alternating Non-Cross-Resistant Combination Chemotherapy or MOPP in Stage IV Hodgkin's Disease

1986 • 370 citations

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

1989 • 230 citations

Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung.

1987 • 146 citations

Patients with Small-Cell Lung Cancer Treated with Combination Chemotherapy with or without Irradiation

1985 • 111 citations

Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.

1990 • 68 citations

Ifosfamide--pharmacologic overview.

1989 • 47 citations

Initial therapy with cisplatin plus VP-16 in small-cell lung cancer.

1986 • 35 citations

Ifosfamide in small cell lung cancer.

1989 • 35 citations

Carboplatin in small cell lung cancer.

1990 • 30 citations

Cisplatin and Etoposide as Second-Line Chemotherapy in Patients with Small Cell Lung Cancer

1988 • 28 citations

Second line chemotherapy in small cell lung cancer

1989 • 28 citations

Combination of chemotherapy and radiotherapy in limited small cell lung carcinoma: results of alternating schedule in 109 patients.

1988 • 18 citations

Phase II Study of Carboplatin in Small Cell Lung Cancer

1988 • 17 citations

A phase II study of the combination of carboplatin and ifosfamide in previously untreated metastatic small cell lung carcinoma

1991 • 10 citations